Johnson & Johnson, Merck and Eli Lilly plan to launch a one-stop database of global clinical trial sites

The clinical investigator database will contain key information such as infrastructure details and good clinical practice (GCP) training records.

For more information, click on the link below (Reuters)

Files

Links

http://www.reuters.com/article/2012/11/15/us-pharmaceuticals-trials-idUSBRE8AE0XS20121115

November 15, 2012